{"id":216834,"date":"2026-08-24T10:50:13","date_gmt":"2026-08-24T05:20:13","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=216834"},"modified":"2026-08-24T10:50:13","modified_gmt":"2026-08-24T05:20:13","slug":"why-senores-pharmaceuticals-l-share-price-52-week-high-2026-08-24","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-senores-pharmaceuticals-l-share-price-52-week-high-2026-08-24\/","title":{"rendered":"SENORES PHARMACEUTICALS L (SENORES) Share Price hits fresh 52-week high at Rs 1,595"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/senores\/senores-pharmaceuticals-l-share-price-today\">SENORES PHARMACEUTICALS L (SENORES)<\/a> share price reached a fresh 52-week high of Rs 1,595 today and stood at Rs 1,595, up 5.3% from the previous close. Market cap was Rs 6,975.51 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong> 24 August 2026 at 10:48 AM IST<\/p>\n<p style=\"margin-top:0!important;\"><strong>SENORES PHARMACEUTICALS L Share Price<\/strong> climbed to Rs 1,595 on 24 August 2026, up Rs 80.35 or 5.3% from the previous close, and set a fresh 52-week high. The company\u2019s market capitalisation stood at Rs 6,975.51 crore. The move places <strong>SENORES PHARMACEUTICALS L Share Price Today<\/strong> in focus for market participants tracking <strong>SENORES PHARMACEUTICALS L Stock News<\/strong>, especially because the supplied data confirms the price event but does not establish a company-specific catalyst. Univest is tracking the stock as it trades at a yearly high and remains one of the more closely watched names in the Healthcare space today.<\/p>\n<p><strong>SENORES PHARMACEUTICALS L Share Price<\/strong> matched the day\u2019s high at Rs 1,595 after opening at Rs 1,520.05 and touching a low of Rs 1,520. The stock closed the gap between the opening level and the session peak by the end of the current snapshot, with turnover at Rs 1.61 crore. For readers searching <strong>SENORES PHARMACEUTICALS L Share Price Today<\/strong> or <strong>SENORES PHARMACEUTICALS L Stock News<\/strong>, the verified takeaway is straightforward: the share price has reached a fresh one-year high, and the data points available here describe the price event rather than its cause. Univest highlights the move in the context of the company\u2019s market cap, sector classification and valuation metrics.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-senores-pharmaceuticals-l-share-price-52-week-high-2026-08-24\/#SENORES_PHARMACEUTICALS_L_Share_Price_Today_Price_Action_Analysis\" title=\"SENORES PHARMACEUTICALS L Share Price Today: Price Action Analysis\">SENORES PHARMACEUTICALS L Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-senores-pharmaceuticals-l-share-price-52-week-high-2026-08-24\/#SENORES_PHARMACEUTICALS_L_SENORES_Fundamental_Analysis\" title=\"SENORES PHARMACEUTICALS L (SENORES) Fundamental Analysis\">SENORES PHARMACEUTICALS L (SENORES) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-senores-pharmaceuticals-l-share-price-52-week-high-2026-08-24\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-senores-pharmaceuticals-l-share-price-52-week-high-2026-08-24\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-senores-pharmaceuticals-l-share-price-52-week-high-2026-08-24\/#Why_Investors_Are_Watching_SENORES_PHARMACEUTICALS_L\" title=\"Why Investors Are Watching SENORES PHARMACEUTICALS L\">Why Investors Are Watching SENORES PHARMACEUTICALS L<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-senores-pharmaceuticals-l-share-price-52-week-high-2026-08-24\/#About_SENORES_PHARMACEUTICALS_L\" title=\"About SENORES PHARMACEUTICALS L\">About SENORES PHARMACEUTICALS L<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-senores-pharmaceuticals-l-share-price-52-week-high-2026-08-24\/#Track_SENORES_PHARMACEUTICALS_L_Share_Price_on_Univest\" title=\"Track SENORES PHARMACEUTICALS L Share Price on Univest\">Track SENORES PHARMACEUTICALS L Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-senores-pharmaceuticals-l-share-price-52-week-high-2026-08-24\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-senores-pharmaceuticals-l-share-price-52-week-high-2026-08-24\/#What_is_SENORES_PHARMACEUTICALS_L_Share_Price_today\" title=\"What is SENORES PHARMACEUTICALS L Share Price today?\">What is SENORES PHARMACEUTICALS L Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-senores-pharmaceuticals-l-share-price-52-week-high-2026-08-24\/#Why_did_SENORES_PHARMACEUTICALS_L_Share_Price_trend_in_news_today\" title=\"Why did SENORES PHARMACEUTICALS L Share Price trend in news today?\">Why did SENORES PHARMACEUTICALS L Share Price trend in news today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-senores-pharmaceuticals-l-share-price-52-week-high-2026-08-24\/#What_is_the_52-week_high_for_SENORES_PHARMACEUTICALS_L\" title=\"What is the 52-week high for SENORES PHARMACEUTICALS L?\">What is the 52-week high for SENORES PHARMACEUTICALS L?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-senores-pharmaceuticals-l-share-price-52-week-high-2026-08-24\/#How_is_SENORES_PHARMACEUTICALS_L_Share_Price_valued_versus_peers\" title=\"How is SENORES PHARMACEUTICALS L Share Price valued versus peers?\">How is SENORES PHARMACEUTICALS L Share Price valued versus peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-senores-pharmaceuticals-l-share-price-52-week-high-2026-08-24\/#What_do_the_latest_fundamentals_show_for_SENORES_PHARMACEUTICALS_L\" title=\"What do the latest fundamentals show for SENORES PHARMACEUTICALS L?\">What do the latest fundamentals show for SENORES PHARMACEUTICALS L?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-senores-pharmaceuticals-l-share-price-52-week-high-2026-08-24\/#How_does_SENORES_PHARMACEUTICALS_L_compare_on_profitability\" title=\"How does SENORES PHARMACEUTICALS L compare on profitability?\">How does SENORES PHARMACEUTICALS L compare on profitability?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-senores-pharmaceuticals-l-share-price-52-week-high-2026-08-24\/#Does_SENORES_PHARMACEUTICALS_L_pay_a_dividend_yield\" title=\"Does SENORES PHARMACEUTICALS L pay a dividend yield?\">Does SENORES PHARMACEUTICALS L pay a dividend yield?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-senores-pharmaceuticals-l-share-price-52-week-high-2026-08-24\/#Which_sector_and_industry_does_SENORES_PHARMACEUTICALS_L_belong_to\" title=\"Which sector and industry does SENORES PHARMACEUTICALS L belong to?\">Which sector and industry does SENORES PHARMACEUTICALS L belong to?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-senores-pharmaceuticals-l-share-price-52-week-high-2026-08-24\/#What_should_investors_monitor_in_SENORES_PHARMACEUTICALS_L_Share_Price_next\" title=\"What should investors monitor in SENORES PHARMACEUTICALS L Share Price next?\">What should investors monitor in SENORES PHARMACEUTICALS L Share Price next?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"SENORES_PHARMACEUTICALS_L_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>SENORES PHARMACEUTICALS L Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,595<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,514.65<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 80.35 (+5.3%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,520.05<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,595<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1,520<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1.61 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6,975.51 crore<\/td>\n<\/tr>\n<\/table>\n<p>SENORES PHARMACEUTICALS L (SENORES) traded at Rs 1,595 versus the previous close of Rs 1,514.65, a rise of 5.3%. The stock opened at Rs 1,520.05, reached a high of Rs 1,595 and touched a low of Rs 1,520.<\/p>\n<p><strong>SENORES PHARMACEUTICALS L Share Price<\/strong> opened at Rs 1,520.05, compared with the previous close of Rs 1,514.65, and moved to Rs 1,595 at the time of this snapshot. The intraday low was Rs 1,520, while the session high was Rs 1,595, which is also the fresh 52-week high. That places the stock at Rs 80.35 above the prior close, equal to a 5.3% rise. Turnover of Rs 1.61 crore shows the value of trades executed during the session, but it does not by itself explain why the move occurred.<\/p>\n<p>For investors following <strong>SENORES PHARMACEUTICALS L Share Price Today<\/strong>, the important point is that the day\u2019s best price aligned with the yearly high. The move is relevant because it changes the recent price reference point and keeps <strong>SENORES PHARMACEUTICALS L Share Price<\/strong> in the list of <strong>52 Week High Stocks<\/strong> on the Indian stock market. Univest notes the event as a factual price milestone rather than a commentary on market behaviour or a corporate trigger.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"SENORES_PHARMACEUTICALS_L_SENORES_Fundamental_Analysis\"><\/span><strong>SENORES PHARMACEUTICALS L (SENORES) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6,975.51 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">55.2x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.24x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.94%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 27.44<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 209.33<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0%<\/td>\n<\/tr>\n<\/table>\n<p>SENORES PHARMACEUTICALS L (SENORES) fundamental metrics show P\/E 55.2x, P\/B 7.24x, ROE 11.78%, ROCE 11.94%. These figures provide context only and are not a buy or sell signal.<\/p>\n<p>SENORES PHARMACEUTICALS L has a market capitalisation of Rs 6975.51 crore, which gives readers a sense of company size before judging valuation. On valuation, P\/E at 55.2x, P\/B at 7.24x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 11.78% and ROCE of 11.94%, helping investors compare shareholder returns and capital efficiency. Additional supplied metrics include EPS of Rs 27.44, book value per share of Rs 209.33, dividend yield of 0%, adding context to earnings, balance-sheet value and historical payout. Against the supplied same industry benchmark, these figures can be compared with benchmark median P\/E of 30.84x, median ROE of 11.81%, median ROCE of 13.68%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">55.2x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">30.84x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">46.28x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.94x to 689.27x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">7.24x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.57x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.78%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.81%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.94%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.68%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 6,975.51 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 506.13 crore<\/td>\n<\/tr>\n<\/table>\n<p>SENORES PHARMACEUTICALS L (SENORES) is classified under sector: Healthcare and industry: Pharmaceuticals &amp; Drugs.<\/p>\n<p>SENORES PHARMACEUTICALS L (SENORES) has a P\/E ratio of 55.2x, which is above the benchmark median of 30.84x, a difference of +78.99%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>SENORES PHARMACEUTICALS L (SENORES) has a ROE of 11.78%, which is below the benchmark median of 11.81%, a difference of -0.25%. SENORES PHARMACEUTICALS L (SENORES) has a ROCE of 11.94%, which is below the benchmark median of 13.68%, a difference of -12.72%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/aartipharm\/aarti-pharmalabs-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Aarti Pharmalabs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">AARTIPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7,404.91<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.38<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.55<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17.59<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/supriya\/supriya-lifescience-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Supriya Lifescience Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUPRIYA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6,478.87<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">32.66<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.3<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">20.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">27.63<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sanofi\/sanofi-india-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sanofi India Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SANOFI<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7,711.34<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">23.82<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.34<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">44.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">55.46<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/innovacap\/innova-captab-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Innova Captab Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">INNOVACAP<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6,243.53<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">40.54<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.75<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">15.04<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/blissgvs\/bliss-gvs-pharma-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Bliss GVS Pharma Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BLISSGVS<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6,187.87<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">45.44<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.02<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.11<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">17.4<\/td>\n<\/tr>\n<\/table>\n<p>SENORES PHARMACEUTICALS L (SENORES) has a P\/E ratio of 55.2x compared with the displayed peer median of 34.74x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 11.78% compares with a peer median of 14.55% across the companies shown in the table. ROCE stood at 11.94% versus the displayed peer median of 17.59%, providing a capital-efficiency comparison. SENORES PHARMACEUTICALS L (SENORES) has a market capitalisation of Rs 6,975.51 crore. Among the 5 peers shown, 2 have a larger market capitalisation.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_SENORES_PHARMACEUTICALS_L\"><\/span><strong>Why Investors Are Watching SENORES PHARMACEUTICALS L<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>SENORES PHARMACEUTICALS L Share Price<\/strong> touched Rs 1,595, which is the fresh 52-week high in the latest snapshot.<\/li>\n<li>The stock rose Rs 80.35, or 5.3%, from the previous close of Rs 1,514.65.<\/li>\n<li>Market capitalisation stands at Rs 6,975.51 crore for <strong>SENORES PHARMACEUTICALS L Share Price<\/strong>.<\/li>\n<li>The company\u2019s P\/E ratio is 55.2 and its P\/B ratio is 7.24, both above the industry medians in the supplied benchmark.<\/li>\n<li>Revenue and net profit both increased in the latest year-on-year figures shown in the supplied financial data.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_SENORES_PHARMACEUTICALS_L\"><\/span><strong>About SENORES PHARMACEUTICALS L<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>SENORES PHARMACEUTICALS L Share Price<\/strong> belongs to the Healthcare sector and the Pharmaceuticals &#038; Drugs industry. The supplied company profile identifies the stock under the NSE and BSE universe through the symbol SENORES and places it within a listed pharmaceutical business context. For <strong>SENORES PHARMACEUTICALS L Share Price Today<\/strong> readers, the main company facts available here are its sector classification, industry grouping and financial metrics. Univest keeps this profile section factual and concise, using only the supplied company and industry information.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_SENORES_PHARMACEUTICALS_L_Share_Price_on_Univest\"><\/span><strong>Track SENORES PHARMACEUTICALS L Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/senores\/senores-pharmaceuticals-l-share-price-today\">SENORES PHARMACEUTICALS L (SENORES) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Investors tracking <strong>SENORES PHARMACEUTICALS L Share Price<\/strong> on Univest can follow live share price updates, 52-week levels, valuation ratios, sector comparison, earnings data, and the shareholding pattern when available. Univest also brings together <strong>SENORES PHARMACEUTICALS L Stock News<\/strong>, company news, market cap and stock analysis in one place for quick review.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_SENORES_PHARMACEUTICALS_L_Share_Price_today\"><\/span><strong>What is SENORES PHARMACEUTICALS L Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SENORES PHARMACEUTICALS L Share Price is Rs 1,595 in the latest snapshot. It is up Rs 80.35, or 5.3%, from the previous close of Rs 1,514.65 and has reached a fresh 52-week high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_SENORES_PHARMACEUTICALS_L_Share_Price_trend_in_news_today\"><\/span><strong>Why did SENORES PHARMACEUTICALS L Share Price trend in news today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data confirms a fresh 52-week high and a 5.3% rise to Rs 1,595. It does not establish a company-specific catalyst, so the article stays limited to the verified price event and valuation context.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52-week_high_for_SENORES_PHARMACEUTICALS_L\"><\/span><strong>What is the 52-week high for SENORES PHARMACEUTICALS L?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The fresh 52-week high for SENORES PHARMACEUTICALS L is Rs 1,595. The current session high matches that level, making it the latest yearly high in the supplied market data. The stock moved 5.3% during the session.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_is_SENORES_PHARMACEUTICALS_L_Share_Price_valued_versus_peers\"><\/span><strong>How is SENORES PHARMACEUTICALS L Share Price valued versus peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SENORES PHARMACEUTICALS L Share Price trades at a P\/E of 55.2 and P\/B of 7.24. Both are above the supplied industry medians and above the peer P\/E range shown here.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_the_latest_fundamentals_show_for_SENORES_PHARMACEUTICALS_L\"><\/span><strong>What do the latest fundamentals show for SENORES PHARMACEUTICALS L?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The company reports market capitalisation of Rs 6,975.51 crore, EPS of Rs 27.44 and book value of Rs 209.33. Revenue and net profit both increased in the latest annual comparison provided.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_SENORES_PHARMACEUTICALS_L_compare_on_profitability\"><\/span><strong>How does SENORES PHARMACEUTICALS L compare on profitability?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> ROE is 11.78% and ROCE is 11.94%. ROE is close to the industry median in the supplied benchmark, while ROCE is below the benchmark median and average. ROE stands at 11.78%.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Does_SENORES_PHARMACEUTICALS_L_pay_a_dividend_yield\"><\/span><strong>Does SENORES PHARMACEUTICALS L pay a dividend yield?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied dividend yield is 0. That means no dividend yield is reflected in the latest dataset, so readers should rely on the reported financial ratios and earnings figures for context.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Which_sector_and_industry_does_SENORES_PHARMACEUTICALS_L_belong_to\"><\/span><strong>Which sector and industry does SENORES PHARMACEUTICALS L belong to?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> SENORES PHARMACEUTICALS L belongs to the Healthcare sector and the Pharmaceuticals &amp; Drugs industry. The supplied benchmark covers 204 same-industry companies and 290 companies in the broader sector. The stock belongs to the Healthcare sector.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_should_investors_monitor_in_SENORES_PHARMACEUTICALS_L_Share_Price_next\"><\/span><strong>What should investors monitor in SENORES PHARMACEUTICALS L Share Price next?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors should monitor whether SENORES PHARMACEUTICALS L Share Price continues to trade around the fresh 52-week high, along with future earnings, valuation ratios and the sector benchmark context already supplied.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>SENORES PHARMACEUTICALS L Share Price hits a new 52-week high at Rs 1,595. marking a 5.3% rise today. Market cap stands at Rs 6,975.51 crore.<\/p>\n","protected":false},"author":29,"featured_media":216833,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-216834","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["216833"],"rank_math_title":["SENORES PHARMACEUTICALS L Share Price: Fresh 52-Week High"],"rank_math_description":["SENORES PHARMACEUTICALS L Share Price hit a fresh 52-week high at Rs 1,595, up 5.3%. Read price action, valuation, and sector context."],"rank_math_focus_keyword":["SENORES PHARMACEUTICALS L Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/SENORES_PHARMACEUTICALS_L_SENORES_Share_Price_hits_fresh_52_week_high_at_Rs_1595_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/216834","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=216834"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/216834\/revisions"}],"predecessor-version":[{"id":216835,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/216834\/revisions\/216835"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/216833"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=216834"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=216834"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=216834"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}